You are viewing the site in preview mode

Skip to main content

Table 2 DAVID analysis of changes in proteins associated with platelet-specific secretion

From: Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer’s disease

Mean log2
(AD/CT)
R1 vs R2
CV, SD%
Symbol Protein Name Ontology Groups
−1.70 0.6% FGA fibrinogen alpha chain A, B, C, E, F
−2.03 7.5% FGB fibrinogen beta chain A, B, C, E, F
−1.69 1.5% FGG fibrinogen gamma chain A, B, C, E, F
−2.02 1.9% VWF von Willebrand factor A, B, C, E
−1.23 39% PROS1 protein S (alpha) B, C, E, F
−1.19 59% FN1 fibronectin 1 B, C, D, F
−1.19 41% SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 B, C, E
−1.47 31% SPARC secreted protein, acidic, cysteine-rich (osteonectin) B, C, F
−2.05 0.9% THBS1 thrombospondin 1 B, C, F
1.47 1.2% GP9 glycoprotein IX (platelet) B, C
−2.82 2.9% C4BPA complement component 4 binding protein, alpha D, E
−1.24 94% SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 E, F
−1.83 66% TF transferrin C
−1.65 10% HP haptoglobin-related protein; haptoglobin D
−1.33 31% SUSD1 sushi domain containing 1 D